Your browser doesn't support javascript.
loading
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade.
Sehgal, Kartik; Portell, Andrew; Ivanova, Elena V; Lizotte, Patrick H; Mahadevan, Navin R; Greene, Jonathan R; Vajdi, Amir; Gurjao, Carino; Teceno, Tyler; Taus, Luke J; Thai, Tran C; Kitajima, Shunsuke; Liu, Derek; Tani, Tetsuo; Noureddine, Moataz; Lau, Christie J; Kirschmeier, Paul T; Liu, David; Giannakis, Marios; Jenkins, Russell W; Gokhale, Prafulla C; Goldoni, Silvia; Pinzon-Ortiz, Maria; Hastings, William D; Hammerman, Peter S; Miret, Juan J; Paweletz, Cloud P; Barbie, David A.
Afiliação
  • Sehgal K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Portell A; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Ivanova EV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Lizotte PH; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Greene JR; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Vajdi A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Gurjao C; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Teceno T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Taus LJ; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Thai TC; ACME Informatics LLC, Claremont, California, USA.
  • Kitajima S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Tani T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Noureddine M; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Lau CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Kirschmeier PT; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Giannakis M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Jenkins RW; Department of Cell Biology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Gokhale PC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Goldoni S; Harvard-MIT Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts, USA.
  • Pinzon-Ortiz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Hastings WD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Hammerman PS; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Miret JJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Paweletz CP; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
J Clin Invest ; 131(2)2021 01 19.
Article em En | MEDLINE | ID: mdl-33151910
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esferoides Celulares / Análise de Célula Única / Receptor de Morte Celular Programada 1 / RNA-Seq / Imunoterapia / Proteínas de Neoplasias / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Clin Invest Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esferoides Celulares / Análise de Célula Única / Receptor de Morte Celular Programada 1 / RNA-Seq / Imunoterapia / Proteínas de Neoplasias / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Clin Invest Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos